HomeStocks

BDX

BCAL Diagnostics Ltd

Director Trades

DateDirectorValue
Jayne Shaw$9,189

Company News

BCAL Diagnostics on Track for Australian Launch of Aventect Pancreatic and Ovarian Cancer Tests
Biotechnology

BCAL Diagnostics on Track for Australian Launch of Aventect Pancreatic and Ovarian Cancer Tests

ASX Investment Opportunities on Show in Singapore During Grand Prix
Hot Topics

ASX Investment Opportunities on Show in Singapore During Grand Prix

BCAL Diagnostics launches groundbreaking blood test to aid early detection of breast cancer
Biotechnology

BCAL Diagnostics launches groundbreaking blood test to aid early detection of breast cancer

Market wrap: local factors push Australian stocks higher
Hot Topics

Market wrap: local factors push Australian stocks higher

BCAL Diagnostics takes major step forward in commercialising blood test for breast cancer screening
Biotechnology

BCAL Diagnostics takes major step forward in commercialising blood test for breast cancer screening

Company Videos

No videos found.